Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia.

Olde Loohuis LM, Mangul S, Ori APS, Jospin G, Koslicki D, Yang HT, Wu T, Boks MP, Lomen-Hoerth C, Wiedau-Pazos M, Cantor RM, de Vos WM, Kahn RS, Eskin E, Ophoff RA.

Transl Psychiatry. 2018 May 10;8(1):96. doi: 10.1038/s41398-018-0107-9.

2.

Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis.

Bock M, Duong YN, Kim A, Allen I, Murphy J, Lomen-Hoerth C.

Neurol Clin Pract. 2017 Dec;7(6):488-498. doi: 10.1212/CPJ.0000000000000397.

PMID:
29431172
3.

Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease - United States.

Marzec NS, Nelson C, Waldron PR, Blackburn BG, Hosain S, Greenhow T, Green GM, Lomen-Hoerth C, Golden M, Mead PS.

MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):607-609. doi: 10.15585/mmwr.mm6623a3.

4.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, Võsa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT, Tazelaar GH, Koppers M, Blokhuis AM, Sproviero W, Jones AR, Kenna KP, van Eijk KR, Harschnitz O, Schellevis RD, Brands WJ, Medic J, Menelaou A, Vajda A, Ticozzi N, Lin K, Rogelj B, Vrabec K, Ravnik-Glavač M, Koritnik B, Zidar J, Leonardis L, Grošelj LD, Millecamps S, Salachas F, Meininger V, de Carvalho M, Pinto S, Mora JS, Rojas-García R, Polak M, Chandran S, Colville S, Swingler R, Morrison KE, Shaw PJ, Hardy J, Orrell RW, Pittman A, Sidle K, Fratta P, Malaspina A, Topp S, Petri S, Abdulla S, Drepper C, Sendtner M, Meyer T, Ophoff RA, Staats KA, Wiedau-Pazos M, Lomen-Hoerth C, Van Deerlin VM, Trojanowski JQ, Elman L, McCluskey L, Basak AN, Tunca C, Hamzeiy H, Parman Y, Meitinger T, Lichtner P, Radivojkov-Blagojevic M, Andres CR, Maurel C, Bensimon G, Landwehrmeyer B, Brice A, Payan CA, Saker-Delye S, Dürr A, Wood NW, Tittmann L, Lieb W, Franke A, Rietschel M, Cichon S, Nöthen MM, Amouyel P, Tzourio C, Dartigues JF, Uitterlinden AG, Rivadeneira F, Estrada K, Hofman A, Curtis C, Blauw HM, van der Kooi AJ, de Visser M, Goris A, Weber M, Shaw CE, Smith BN, Pansarasa O, Cereda C, Del Bo R, Comi GP, D'Alfonso S, Bertolin C, Sorarù G, Mazzini L, Pensato V, Gellera C, Tiloca C, Ratti A, Calvo A, Moglia C, Brunetti M, Arcuti S, Capozzo R, Zecca C, Lunetta C, Penco S, Riva N, Padovani A, Filosto M, Muller B, Stuit RJ; PARALS Registry; SLALOM Group; SLAP Registry; FALS Sequencing Consortium; SLAGEN Consortium; NNIPPS Study Group, Blair I, Zhang K, McCann EP, Fifita JA, Nicholson GA, Rowe DB, Pamphlett R, Kiernan MC, Grosskreutz J, Witte OW, Ringer T, Prell T, Stubendorff B, Kurth I, Hübner CA, Leigh PN, Casale F, Chio A, Beghi E, Pupillo E, Tortelli R, Logroscino G, Powell J, Ludolph AC, Weishaupt JH, Robberecht W, Van Damme P, Franke L, Pers TH, Brown RH, Glass JD, Landers JE, Hardiman O, Andersen PM, Corcia P, Vourc'h P, Silani V, Wray NR, Visscher PM, de Bakker PI, van Es MA, Pasterkamp RJ, Lewis CM, Breen G, Al-Chalabi A, van den Berg LH, Veldink JH.

Nat Genet. 2016 Sep;48(9):1043-8. doi: 10.1038/ng.3622. Epub 2016 Jul 25.

5.

Cognitive-behavioral changes in amyotrophic lateral sclerosis: Screening prevalence and impact on patients and caregivers.

Bock M, Duong YN, Kim A, Allen I, Murphy J, Lomen-Hoerth C.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):366-73. doi: 10.3109/21678421.2016.1165257. Epub 2016 Apr 4.

PMID:
27043386
6.

Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional Population.

Fournier CN, Murphy A, Loci L, Mitsumoto H, Lomen-Hoerth C, Kisanuki Y, Simmons Z, Maragakis NJ, McVey AL, Al-Lahham T, Heiman-Patterson TD, Andrews J, McDonnell E, Cudkowicz M, Atassi N.

J Clin Neuromuscul Dis. 2016 Mar;17(3):99-105. doi: 10.1097/CND.0000000000000102.

7.

Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H; ALS COSMOS.

Neurology. 2016 Mar 1;86(9):813-20. doi: 10.1212/WNL.0000000000002305. Epub 2016 Jan 22.

8.

Prospective study of cost of care at multidisciplinary ALS centers adhering to American Academy of Neurology (AAN) ALS practice parameters.

Boylan K, Levine T, Lomen-Hoerth C, Lyon M, Maginnis K, Callas P, Gaspari C, Tandan R; ALS Center Cost Evaluation W/Standards & Satisfaction (Access) Consortium.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):119-27. doi: 10.3109/21678421.2015.1091478. Epub 2015 Oct 13.

PMID:
26462131
9.

Amyotrophic lateral sclerosis.

Malik R, Lui A, Lomen-Hoerth C.

Semin Neurol. 2014 Nov;34(5):534-41. doi: 10.1055/s-0034-1396007. Epub 2014 Dec 17. Review.

PMID:
25520025
10.

Quantitative ultrasound of denervated hand muscles.

Simon NG, Ralph JW, Lomen-Hoerth C, Poncelet AN, Vucic S, Kiernan MC, Kliot M.

Muscle Nerve. 2015 Aug;52(2):221-30. doi: 10.1002/mus.24519. Epub 2015 May 23.

PMID:
25388871
11.

The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS.

Murphy J, Ahmed F, Lomen-Hoerth C.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):24-30. doi: 10.3109/21678421.2014.960873. Epub 2014 Oct 10.

PMID:
25301548
12.

Quantifying disease progression in amyotrophic lateral sclerosis.

Simon NG, Turner MR, Vucic S, Al-Chalabi A, Shefner J, Lomen-Hoerth C, Kiernan MC.

Ann Neurol. 2014 Nov;76(5):643-57. doi: 10.1002/ana.24273. Epub 2014 Sep 30. Review.

13.

An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.

Pattee GL, Wymer JP, Lomen-Hoerth C, Appel SH, Formella AE, Pope LE.

Curr Med Res Opin. 2014 Nov;30(11):2255-65. doi: 10.1185/03007995.2014.940040. Epub 2014 Jul 28.

14.

Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey.

Rabkin J, Ogino M, Goetz R, McElhiney M, Hupf J, Heitzman D, Heiman-Patterson T, Miller R, Katz J, Lomen-Hoerth C, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):185-91. doi: 10.3109/21678421.2014.896928. Epub 2014 Apr 10.

PMID:
24720451
15.

Patterns of clinical and electrodiagnostic abnormalities in early amyotrophic lateral sclerosis.

Simon NG, Lomen-Hoerth C, Kiernan MC.

Muscle Nerve. 2014 Dec;50(6):894-9. doi: 10.1002/mus.24244. Epub 2014 Oct 31.

PMID:
24647900
16.

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA; ALS COSMOS Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):192-203. doi: 10.3109/21678421.2013.864312. Epub 2014 Feb 24.

17.

Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block?

Simon NG, Ayer G, Lomen-Hoerth C.

Neurology. 2013 Dec 10;81(24):2116-20. doi: 10.1212/01.wnl.0000437301.28441.7e. Epub 2013 Nov 8.

18.

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.

Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL 3rd, Caselli R, Mackenzie IR, Miller BL, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Younkin SG, Petersen RC, Ertekin-Taner N, Uitti RJ, Meschia JF, Boylan KB, Boeve BF, Graff-Radford NR, Wszolek ZK, Dickson DW, Rademakers R, Ross OA.

Mol Neurodegener. 2013 Jun 21;8:19. doi: 10.1186/1750-1326-8-19.

19.

Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.

Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, Floeter MK, Henderson C, Lomen-Hoerth C, Macklis JD, McCluskey L, Mitsumoto H, Przedborski S, Rothstein J, Trojanowski JQ, van den Berg LH, Ringel S.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1:5-18. doi: 10.3109/21678421.2013.778548.

20.

Influenza-associated global amnesia and hippocampal imaging abnormality.

Lopez J, Lomen-Hoerth C, Deutsch GK, Kerchner GA, Koshy A.

Neurocase. 2014 Aug;20(4):446-51. doi: 10.1080/13554794.2013.791864. Epub 2013 May 22.

21.

ALS Untangled No. 20: the Deanna protocol.

ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):319-23. doi: 10.3109/21678421.2013.788405. Epub 2013 May 2. Review. No abstract available.

PMID:
23638638
22.

Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation.

Takada LT, Pimentel ML, Dejesus-Hernandez M, Fong JC, Yokoyama JS, Karydas A, Thibodeau MP, Rutherford NJ, Baker MC, Lomen-Hoerth C, Rademakers R, Miller BL.

Arch Neurol. 2012 Sep;69(9):1149-53. doi: 10.1001/archneurol.2012.650.

23.

Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.

Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Knopman DS, Kretzschmar HA, Neumann M, Caselli RJ, White CL 3rd, Mackenzie IR, Petersen RC, Strong MJ, Miller BL, Boeve BF, Uitti RJ, Boylan KB, Wszolek ZK, Graff-Radford NR, Dickson DW, Ross OA, Rademakers R.

Neurobiol Aging. 2012 Dec;33(12):2950.e5-7. doi: 10.1016/j.neurobiolaging.2012.07.005. Epub 2012 Jul 26.

24.

C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository.

Rutherford NJ, DeJesus-Hernandez M, Baker MC, Kryston TB, Brown PE, Lomen-Hoerth C, Boylan K, Wszolek ZK, Rademakers R.

Neurology. 2012 Jul 31;79(5):482-3. doi: 10.1212/WNL.0b013e31826170f1. Epub 2012 Jul 18. No abstract available.

25.

Organ donation after cardiac death in amyotrophic lateral sclerosis.

Toossi S, Lomen-Hoerth C, Josephson SA, Gropper MA, Roberts J, Patton K, Smith WS.

Ann Neurol. 2012 Feb;71(2):154-6. doi: 10.1002/ana.22525. Epub 2012 Feb 14.

PMID:
22334377
26.

Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis.

Olney NT, Goodkind MS, Lomen-Hoerth C, Whalen PK, Williamson CA, Holley DE, Verstaen A, Brown LM, Miller BL, Kornak J, Levenson RW, Rosen HJ.

Brain. 2011 Dec;134(Pt 12):3458-69. doi: 10.1093/brain/awr297. Epub 2011 Dec 6.

27.

Clinical phenomenology and neuroimaging correlates in ALS-FTD.

Lomen-Hoerth C.

J Mol Neurosci. 2011 Nov;45(3):656-62. doi: 10.1007/s12031-011-9636-x. Epub 2011 Oct 5. Review.

PMID:
21971978
28.

Ataxin-2 repeat-length variation and neurodegeneration.

Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Woodruff BK, Knopman DS, White CL 3rd, Van Gerpen JA, Meschia JF, Mackenzie IR, Boylan K, Boeve BF, Miller BL, Strong MJ, Uitti RJ, Younkin SG, Graff-Radford NR, Petersen RC, Wszolek ZK, Dickson DW, Rademakers R.

Hum Mol Genet. 2011 Aug 15;20(16):3207-12. doi: 10.1093/hmg/ddr227. Epub 2011 May 24.

29.

Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis.

Rutherford NJ, Finch NA, DeJesus-Hernandez M, Crook RJ, Lomen-Hoerth C, Wszolek ZK, Uitti RJ, Graff-Radford NR, Rademakers R.

Neurobiol Aging. 2012 Feb;33(2):424.e23-4. doi: 10.1016/j.neurobiolaging.2010.09.029. Epub 2010 Nov 12.

30.

Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions.

Huang EJ, Zhang J, Geser F, Trojanowski JQ, Strober JB, Dickson DW, Brown RH Jr, Shapiro BE, Lomen-Hoerth C.

Brain Pathol. 2010 Nov;20(6):1069-76. doi: 10.1111/j.1750-3639.2010.00413.x. Epub 2010 Jun 23. Erratum in: Brain Pathol. 2010 Nov;20(6):1119.

31.

Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis.

Merrilees J, Klapper J, Murphy J, Lomen-Hoerth C, Miller BL.

Amyotroph Lateral Scler. 2010 May 3;11(3):298-302. doi: 10.3109/17482961003605788.

32.

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group.

Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743.

33.

Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN, Bruijn L, Ince P, Figlewicz D.

Amyotroph Lateral Scler. 2009 Jun;10(3):131-46. Erratum in: Amyotroph Lateral Scler. 2009 Aug;10(4):252.

PMID:
19462523
34.

Nouns, verbs, and ALS.

Albert SM, Lomen-Hoerth C.

Neurology. 2008 Oct 28;71(18):1388-9. doi: 10.1212/01.wnl.0000326062.11565.53. Epub 2008 Sep 10. No abstract available.

PMID:
18784376
35.

Amyotrophic lateral sclerosis from bench to bedside.

Lomen-Hoerth C.

Semin Neurol. 2008 Apr;28(2):205-11. doi: 10.1055/s-2008-1062265. Review.

PMID:
18351522
36.

Whole-genome analysis of sporadic amyotrophic lateral sclerosis.

Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF, Stamper C, Jensen KR, Letizia D, Hesterlee SE, Pestronk A, Levine T, Bertorini T, Graves MC, Mozaffar T, Jackson CE, Bosch P, McVey A, Dick A, Barohn R, Lomen-Hoerth C, Rosenfeld J, O'connor DT, Zhang K, Crook R, Ryberg H, Hutton M, Katz J, Simpson EP, Mitsumoto H, Bowser R, Miller RG, Appel SH, Stephan DA.

N Engl J Med. 2007 Aug 23;357(8):775-88. Epub 2007 Aug 1.

37.

Continuum of frontal lobe impairment in amyotrophic lateral sclerosis.

Murphy JM, Henry RG, Langmore S, Kramer JH, Miller BL, Lomen-Hoerth C.

Arch Neurol. 2007 Apr;64(4):530-4.

PMID:
17420314
38.

Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis.

Murphy J, Henry R, Lomen-Hoerth C.

Arch Neurol. 2007 Mar;64(3):330-4. Review.

PMID:
17353375
39.

Dysphagia in patients with frontotemporal lobar dementia.

Langmore SE, Olney RK, Lomen-Hoerth C, Miller BL.

Arch Neurol. 2007 Jan;64(1):58-62.

PMID:
17210809
40.

Comparison of family histories in FTLD subtypes and related tauopathies.

Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, Lomen-Hoerth C, Wilhelmsen KC, Lee VM, Grossman M, Miller BL.

Neurology. 2005 Dec 13;65(11):1817-9.

PMID:
16344531
41.

The effects of executive and behavioral dysfunction on the course of ALS.

Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, Kohn MA, Lomen-Hoerth C.

Neurology. 2005 Dec 13;65(11):1774-7.

PMID:
16344521
42.

A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD.

Chang JL, Lomen-Hoerth C, Murphy J, Henry RG, Kramer JH, Miller BL, Gorno-Tempini ML.

Neurology. 2005 Jul 12;65(1):75-80.

PMID:
16009889
43.

Exit strategies in ALS: an influence of depression or despair?

Olney RK, Lomen-Hoerth C.

Neurology. 2005 Jul 12;65(1):9-10. No abstract available.

PMID:
16009877
44.

A clinical trial of creatine in ALS.

Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, Pestronk A, Caress J, Donofrio P, Sorenson E, Bradley W, Lomen-Hoerth C, Pioro E, Rezania K, Ross M, Pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, Smith-Palmer T, MacDonald D, Burke D; NEALS Consortium.

Neurology. 2004 Nov 9;63(9):1656-61.

PMID:
15534251
45.

Characterization of amyotrophic lateral sclerosis and frontotemporal dementia.

Lomen-Hoerth C.

Dement Geriatr Cogn Disord. 2004;17(4):337-41.

PMID:
15178949
46.

17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.

Wilhelmsen KC, Forman MS, Rosen HJ, Alving LI, Goldman J, Feiger J, Lee JV, Segall SK, Kramer JH, Lomen-Hoerth C, Rankin KP, Johnson J, Feiler HS, Weiner MW, Lee VM, Trojanowski JQ, Miller BL.

Arch Neurol. 2004 Mar;61(3):398-406.

PMID:
15023818
47.

ALS treatment strikes out while trying for a homer: the topiramate trial.

Kaufmann P, Lomen-Hoerth C.

Neurology. 2003 Aug 26;61(4):434-5. No abstract available.

PMID:
12939412
48.

Statistical motor unit number estimation: from theory to practice.

Lomen-Hoerth C, Slawnych MP.

Muscle Nerve. 2003 Sep;28(3):263-72. Review.

PMID:
12929186
49.

Cognitive impairment, frontotemporal dementia, and the motor neuron diseases.

Strong MJ, Lomen-Hoerth C, Caselli RJ, Bigio EH, Yang W.

Ann Neurol. 2003;54 Suppl 5:S20-3. Review. No abstract available.

PMID:
12833364
50.

Are amyotrophic lateral sclerosis patients cognitively normal?

Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B.

Neurology. 2003 Apr 8;60(7):1094-7.

PMID:
12682312

Supplemental Content

Loading ...
Support Center